InspireMD vs Nexgel
NSPR and NXGL side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NSPR and NXGL compare
Nexgel is the larger company, worth 1.2 times as much as InspireMD ($37.0M against $30.2M).
InspireMD grew revenue faster over the last twelve months (53.4% versus 3.4% for Nexgel).
Nexgel keeps more of each dollar of sales as profit, with a net margin of −51.3% compared with −484% at InspireMD.
InspireMD scores higher on the StockData Score (10 against 6 for Nexgel), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NSPR | NXGL |
|---|---|---|
| Size and price | ||
| Market cap | $30.2M | $37.0M |
| Share price | $0.650 | $3.80 |
| Change, 1 year | −69.2% | −90.1% |
| Change, 5 years | −82.1% | – |
| Beta (5Y) | −0.87 | 1.08 |
| Employees | 127 | 19 |
| StockData Score | ||
| Total score | 10 (better) | 6 |
| Valuation score | 3 (better) | 2 |
| Growth score | 2 (better) | 1 |
| Performance score | 0 | 1 (better) |
| Health score | 5 (better) | 2 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 2.8× (better) | 3.1× |
| P/B | 1.0× (better) | 7.5× |
| FCF yield | −141% | – |
| Fair value | $1.40 | $12.33 |
| Margin of safety | 53.7% | 69.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 53.4% (better) | 3.4% |
| Revenue growth, 5Y average | 29.3% | 76.1% (better) |
| Profitability | ||
| Gross margin | 18.1% | 35.1% (better) |
| Operating margin | −494% | −44.8% (better) |
| Net margin | −484% | −51.3% (better) |
| FCF margin | −392% | – |
| Return on equity | −203% | −129% (better) |
| Return on invested capital | −4320% | −91.0% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.09 (better) |
| Current ratio | 3.80 (better) | 0.43 |
| Altman Z-score | −11.97 | −0.89 (better) |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 53.6% | 9.0% |
| Held by insiders | 31.6% | 13.2% |
| Insider net buying, 12 months | $369K | $721K (better) |
| Short interest, % of float | 0.79% | – |
Go deeper
- NSPR stock overview
- NSPR income statement
- NSPR valuation and score
- NXGL stock overview
- NXGL income statement
- NXGL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.